Cargando…
Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p/METTL3/m(6)A/p21 pathway
Evidence suggests that metformin might be a potential candidate for breast cancer treatment. Yet, its relevant molecular mechanisms remain to be fully investigated. We found that metformin could suppress the N6-methyladenosine (m(6)A) level in breast cancer cells significantly. The latter has an ess...
Autores principales: | Cheng, Lin, Zhang, Xu, Huang, Yu-Zhou, Zhu, Yu-Lan, Xu, Ling-Yun, Li, Zhi, Dai, Xin-Yuan, Shi, Liang, Zhou, Xu-Jie, Wei, Ji-Fu, Ding, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801402/ https://www.ncbi.nlm.nih.gov/pubmed/33431790 http://dx.doi.org/10.1038/s41389-020-00290-y |
Ejemplares similares
-
Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer
por: ABUE, MAKOTO, et al.
Publicado: (2014) -
Diagnostic Potential of Plasma Extracellular Vesicle miR-483-3p and Let-7d-3p for Sepsis
por: Qiu, Guanguan, et al.
Publicado: (2022) -
IGF2‐derived miR‐483‐3p associated with Hirschsprung's disease by targeting FHL1
por: Zhi, Zhengke, et al.
Publicado: (2018) -
Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic–pharmacodynamic profiles of rivaroxaban
por: Zhang, Hanxu, et al.
Publicado: (2022) -
Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice
por: Li, Fuyuan, et al.
Publicado: (2014)